A carregar...

Optimizing outcomes for patients with newly diagnosed multiple myeloma eligible for transplantation

High-dose therapy with autologous stem cell transplantation (HDT–ASCT) has been considered to be the standard frontline treatment for younger, fit patients with multiple myeloma (MM) since the 1990s. Efforts continue to optimize the use of HDT–ASCT with the aim of improving outcomes. One strategy ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leukemia Suppl
Main Authors: Moreau, P, Touzeau, C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4851188/
https://ncbi.nlm.nih.gov/pubmed/27175256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leusup.2013.4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!